Article
Otolaryngologic Manifestations of the 22q11.2 Deletion Syndrome
1 Dec 2002
Abstract excerpt
BACKGROUND: The 22q11.2 chromosome deletion syndrome occurs at a frequency of 1 in 4000 live births. Fluorescent in situ hybridization is a reliable means of testing for this genetic abnormality. OBJECTIVE: To describe the otolaryngologic manifestations of the 22q11.2 deletion syndrome to improve recognition and management of these disorders. PATIENTS AND DESIGN: A retrospective medical record review of 102...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
